Commentary: The small-molecule 'penalty' is a threat to Mass. biotech sector
In Massachusetts, the convergence of brilliant minds and entrepreneurial spirit has given rise to transformative breakthroughs that are shaping the future of medicine: mRNA vaccines, targeted cancer therapies, gene-editing technology, and more. These advances are not an accident, but rather a product of an ecosystem of academic research institutions, venture funds, small biotech companies and large manufacturers.
This ecosystem is now adapting to new realities set in place by last year's Inflation… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 9, 2024 Category: Pharmaceuticals Authors: Kendalle Burlin O'Connell, John Stanford Source Type: news
News at a glance: Weird early trees, CERN ’s next big collider, and protecting U.S. gray wolves
PALEONTOLOGY
Rare fossil reveals weird early tree
The earliest trees, from nearly 400 million years ago, are known mostly from fossils of their trunks; their leaves and canopy shapes have remained a mystery. A newly reported, 350-million-year-old tree found in Canada provides a vivid answer for one such primordial species: As if having a perpetual bad hair day,
a thick crown of spiky leaves stuck out perpendicularly from the trunk
. Scientists named the tree
Sanfordiacaulis densifolia
, after the owner of the New Brunswick quarry where they found five specimens. The fossils, amo...
Source: ScienceNOW - February 8, 2024 Category: Science Source Type: news
Zero Cases Of Cervical Cancer In Those Who Received HPV Vaccine, Study.
Women who received the HPV vaccine prior to age 14 years had no cases of cervical cancer, according to a recent study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 5, 2024 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Zero Cases Of Cervical Cancer In Those Who Received HPV Vaccine, Study Finds
There are over 11,000 new cases of cervical cancer annually in the U.S., with nearly 4,000 cervical cancer deaths each year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 5, 2024 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Moderna cancer vaccine trial begins in UK, scientists hopeful of 'dawn of a new age of treatments'
Cancer patients in the UK are part of a global trial for the mRNA therapy mRNA-4359. The phase 1/2 clinical trial, sponsored by Moderna, aims to evaluate the safety and efficacy of the therapy in treating melanoma, lung cancer, and other solid tumor cancers. The therapy uses mRNA to train the immune system to recognize and combat cancer cells expressing common tumor markers. The trial is conducted in collaboration with Moderna-UK Strategic Partnership and aims to bring mRNA vaccine manufacturing to the UK. The first patient to receive mRNA-4359 was an 81-year-old man with treatment-resistant malignant melanoma. (Source: The Economic Times)
Source: The Economic Times - February 5, 2024 Category: Consumer Health News Source Type: news
Huge cancer breakthrough as new vaccine could cure illnesses in 'dawn of a new age'
Moderna, one of the providers of Covid vaccines, has developed a new jab that could cure cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - February 4, 2024 Category: Consumer Health News Source Type: news
Scottish Study On HPV Vaccine Shows Remarkable Reduction In Cervical Cancer Incidence
Scottish observational study on the effectiveness of the HPV vaccine shows that no cases of cervical cancer were recorded in women immunized at 12 or 13 years of age. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 4, 2024 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Kenya: Health Ministry Conducts Cancer Screening, Vaccination Ahead of World Cancer Day
[Capital FM] Nairobi -- The Ministry of Health conducted a cancer vaccination and screening campaign in Kirinyaga ahead of World Cancer Day on Sunday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 4, 2024 Category: African Health Tags: East Africa Health and Medicine Kenya Noncommunicable Diseases Source Type: news
Laying bedrock for development, growth: Dilip Shanghvi, MD, Sun Pharma
The interim budget exemplifies the government's dedication to Viksit Bharat. It focuses on fortifying the economy, boosting infrastructure, and promoting green growth through bio-manufacturing. The budget also expands universal health coverage and introduces the cervical cancer vaccination program. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 1, 2024 Category: Pharmaceuticals Source Type: news
Interim Budget 2024: Laying bedrock for development, growth
The interim budget exemplifies the government's dedication to Viksit Bharat. It focuses on fortifying the economy, boosting infrastructure, and promoting green growth through bio-manufacturing. The budget also expands universal health coverage and introduces the cervical cancer vaccination program. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news
Budget 2024: Prescription for cervical cancer vaccine, new medical colleges
The government is planning to include the human papillomavirus (HPV) vaccine in the country's immunisation program, potentially making vaccines to prevent cervical cancer more affordable. Finance Minister Nirmala Sitharaman stated that the government aims to encourage vaccination for girls aged 9 to 14 to prevent cervical cancer. Currently, the HPV vaccine is available in private hospitals at a cost of up to ₹4,000 per dose. Additionally, the government plans to establish more medical colleges and upgrade Anganwadi centers for improved healthcare services and nutrition delivery. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news
World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2).
In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news
Budget 2024: Govt actively considering rolling out of HPV vaccine for cervical cancer, says FM
Budget 2024: During her Budget speech, Finance Minister Nirmala Sitharaman said that the government will encourage vaccination for girls in the age group of 9 to 14 years for providing prevention of cervical cancer. She added that the government is actively considering rolling out the HPV vaccine in the country’s immunisation programme. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 1, 2024 Category: Pharmaceuticals Source Type: news
Phase I Trial Improves Mesothelioma Survival More Than 200%
Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave the third dose of GPS alongside the checkpoint inhibitor Opdivo (nivolumab).
President of Sellas, Angelos Stergiou, stated in a press release, “As we had hypothesized in the past, this increase in survival appears to be consistent with long-...
Source: Asbestos and Mesothelioma News - January 31, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Mesothelioma Source Type: news
Early Mesothelioma Vaccine Testing Shows Survival Gains
Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave the third dose of GPS alongside the checkpoint inhibitor Opdivo (nivolumab).
President of Sellas, Angelos Stergiou, stated in a press release, “As we had hypothesized in the past, this increase in survival appears to be consistent with long-...
Source: Asbestos and Mesothelioma News - January 31, 2024 Category: Environmental Health Authors: Sean Marchese Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Mesothelioma Source Type: news
